Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending May 27, 2022.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
A year after the 2021 ASA/AHA stroke prevention guidelines were released, experts in the field—Mitchell S.V. Elkind, MD, MS, MPhil, and Jose Gutierrez, MD, MPH—shared some of the most notable changes to care and the areas that still need to be addressed going forward.
The assistant professor of neurology at The Ohio State University Wexner Medical Center provided insight on finding strategies to prevent neurodegeneration in multiple sclerosis, in a conversation around World MS Day.
The founder and chief medical officer of Omniscient Neurotechnology provided commentary on expanding the brain map, the use of advanced technology in care, and the need to familiarize clinicians with connectomics.
The new ASA/AHA guidance, updating the prior 2015 publication, provides several significant recommendations and changes, including those for the use of antiseizure medications in patients with ICH.
The executive director of the Bensalem Rescue Squad, in Pennsylvania, spoke specifically about how the Jefferson MSU program has shifted the paradigm of care that EMS can provide to individuals in the community.